4//SEC Filing
DE GREEF RODERICK 4
Accession 0001437749-22-028232
CIK 0000834365other
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 8:00 PM ET
Size
10.8 KB
Accession
0001437749-22-028232
Insider Transaction Report
Form 4
DE GREEF RODERICK
Director
Transactions
- Sale
Common Stock
2022-11-28$21.44/sh−5,400$115,776→ 69,719 total - Sale
Common Stock
2022-11-29$20.20/sh−1,500$30,300→ 68,219 total - Sale
Common Stock
2022-11-28$20.75/sh−4,600$95,450→ 75,119 total - Sale
Common Stock
2022-11-30$20.59/sh−33,905$698,104→ 34,314 total
Footnotes (5)
- [F1]As previously disclosed, the reporting person is retiring from his position as President and Chief Operating Officer effective January 3, 2023. The reporting person is selling these shares for retirement planning.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.29 to $21.29, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.30 to $21.64, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.13 to $20.25, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.02 to $20.83, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
BIOLIFE SOLUTIONS INC
CIK 0000834365
Entity typeother
Related Parties
1- filerCIK 0001241181
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 8:00 PM ET
- Size
- 10.8 KB